vitrolife limited Company Information
Company Number
04628698
Website
www.vitrolife.comRegistered Address
1 chapel street, warwick, CV34 4HL
Industry
Specialist medical practice activities
Telephone
08000320013
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
vitrolife ab 100%
vitrolife limited Estimated Valuation
Pomanda estimates the enterprise value of VITROLIFE LIMITED at £3.5m based on a Turnover of £7.4m and 0.47x industry multiple (adjusted for size and gross margin).
vitrolife limited Estimated Valuation
Pomanda estimates the enterprise value of VITROLIFE LIMITED at £2.9m based on an EBITDA of £694.9k and a 4.17x industry multiple (adjusted for size and gross margin).
vitrolife limited Estimated Valuation
Pomanda estimates the enterprise value of VITROLIFE LIMITED at £2.7m based on Net Assets of £1.4m and 1.95x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Vitrolife Limited Overview
Vitrolife Limited is a live company located in warwick, CV34 4HL with a Companies House number of 04628698. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in January 2003, it's largest shareholder is vitrolife ab with a 100% stake. Vitrolife Limited is a mature, mid sized company, Pomanda has estimated its turnover at £7.4m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Vitrolife Limited Health Check
Pomanda's financial health check has awarded Vitrolife Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
4 Regular
5 Weak
Size
annual sales of £7.4m, make it larger than the average company (£513.1k)
- Vitrolife Limited
£513.1k - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a faster rate (4.9%)
- Vitrolife Limited
4.9% - Industry AVG
Production
with a gross margin of 55.6%, this company has a comparable cost of product (55.6%)
- Vitrolife Limited
55.6% - Industry AVG
Profitability
an operating margin of 4.5% make it less profitable than the average company (12.9%)
- Vitrolife Limited
12.9% - Industry AVG
Employees
with 14 employees, this is similar to the industry average (12)
14 - Vitrolife Limited
12 - Industry AVG
Pay Structure
on an average salary of £29.5k, the company has an equivalent pay structure (£29.5k)
- Vitrolife Limited
£29.5k - Industry AVG
Efficiency
resulting in sales per employee of £531.4k, this is more efficient (£78.2k)
- Vitrolife Limited
£78.2k - Industry AVG
Debtor Days
it gets paid by customers after 73 days, this is later than average (33 days)
- Vitrolife Limited
33 days - Industry AVG
Creditor Days
its suppliers are paid after 5 days, this is quicker than average (47 days)
- Vitrolife Limited
47 days - Industry AVG
Stock Days
it holds stock equivalent to 16 days, this is in line with average (15 days)
- Vitrolife Limited
15 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 17 weeks, this is less cash available to meet short term requirements (78 weeks)
17 weeks - Vitrolife Limited
78 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 52.7%, this is a higher level of debt than the average (33.8%)
52.7% - Vitrolife Limited
33.8% - Industry AVG
VITROLIFE LIMITED financials
Vitrolife Limited's latest turnover from December 2022 is estimated at £7.4 million and the company has net assets of £1.4 million. According to their latest financial statements, Vitrolife Limited has 14 employees and maintains cash reserves of £528.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 8,184,081 | 7,423,880 | 6,222,493 | 3,748,962 | 3,478,054 | 2,990,177 | 2,710,858 | 2,286,107 | 1,964,215 | 1,497,914 | 1,308,274 | 1,365,794 | 881,286 | |
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cost Of Sales | 5,871,115 | 5,297,560 | 3,862,152 | 2,790,756 | 2,574,926 | 2,361,633 | 2,154,320 | 1,823,512 | 1,464,599 | 1,078,435 | 960,598 | 1,089,058 | 654,138 | |
Gross Profit | 2,312,966 | 2,126,320 | 2,360,341 | 958,206 | 903,128 | 628,544 | 556,538 | 462,595 | 499,616 | 419,479 | 347,676 | 276,736 | 227,148 | |
Admin Expenses | 1,948,293 | 1,796,013 | 2,003,663 | 767,917 | 729,051 | 545,914 | 469,349 | 411,552 | 442,050 | 355,843 | 288,013 | 212,966 | 125,071 | |
Operating Profit | 364,673 | 330,307 | 356,678 | 190,289 | 174,077 | 82,630 | 87,189 | 51,043 | 57,566 | 63,636 | 59,663 | 63,770 | 102,077 | |
Interest Payable | 2,062 | 37,596 | 40,726 | 0 | 0 | 37,089 | 6,026 | 0 | 0 | 0 | 5,616 | 2,819 | 0 | |
Interest Receivable | 3,797 | 4,016 | 2,684 | 1,095 | 0 | 0 | 0 | 0 | 5,687 | 6,767 | 0 | 0 | 73 | |
Pre-Tax Profit | 366,408 | 296,727 | 318,636 | 191,384 | 174,077 | 119,719 | 93,215 | 55,179 | 63,770 | 70,403 | 54,047 | 60,951 | 102,150 | |
Tax | -138,780 | -170,636 | -65,588 | -41,416 | -37,478 | -29,002 | -23,151 | -17,326 | -19,470 | -15,617 | -10,588 | -21,440 | -28,131 | |
Profit After Tax | 227,628 | 126,091 | 253,048 | 149,968 | 136,599 | 90,717 | 70,064 | 37,853 | 44,300 | 54,786 | 43,459 | 39,511 | 74,019 | |
Dividends Paid | 0 | 0 | 0 | 0 | 159,814 | 350,168 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Retained Profit | 227,628 | 126,091 | 253,048 | 149,968 | -23,215 | -259,451 | 70,064 | 37,853 | 44,300 | 54,786 | 43,459 | 39,511 | 74,019 | |
Employee Costs | 1,212,901 | 1,120,710 | 1,196,824 | 434,599 | 443,937 | 295,896 | 271,482 | 183,930 | 268,268 | 208,386 | 181,874 | 122,265 | 82,954 | |
Number Of Employees | 14 | 13 | 13 | 13 | 5 | 6 | 4 | 4 | 4 | 3 | 3 | 3 | 2 | 4 |
EBITDA* | 724,673 | 690,307 | 566,678 | 190,289 | 174,077 | 82,630 | 88,379 | 54,022 | 60,518 | 65,850 | 59,663 | 63,770 | 102,077 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 1,104 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,190 | 3,690 | 6,642 | 0 | 0 | 0 |
Intangible Assets | 510,000 | 870,000 | 1,030,000 | 1,590,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 511,104 | 870,000 | 1,030,000 | 1,590,000 | 0 | 0 | 0 | 0 | 1,190 | 3,690 | 6,642 | 0 | 0 | 0 |
Stock & work in progress | 146,937 | 261,782 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 1,493,145 | 1,460,917 | 2,939,260 | 1,247,270 | 463,971 | 444,150 | 440,082 | 377,530 | 282,440 | 236,678 | 255,905 | 190,355 | 206,259 | 192,620 |
Group Debtors | 95,461 | 43,301 | 11,688 | 32,484 | 224,461 | 0 | 0 | 0 | 0 | 339,106 | 332,902 | 559,335 | 496,178 | 328,892 |
Misc Debtors | 174,746 | 124,190 | 242,013 | 380,927 | 21,440 | 27,685 | 25,926 | 21,261 | 9,346 | 7,855 | 4,700 | 0 | 8,385 | 6,890 |
Cash | 528,241 | 471,391 | 369,117 | 270,154 | 49,582 | 207,795 | 244,439 | 522,553 | 421,651 | 366,184 | 126,345 | 98,911 | 78,674 | 195,924 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 2,438,530 | 2,361,581 | 3,562,078 | 1,930,835 | 759,454 | 679,629 | 710,447 | 921,344 | 713,437 | 949,823 | 719,852 | 848,601 | 789,496 | 724,326 |
total assets | 2,949,634 | 3,231,581 | 4,592,078 | 3,520,835 | 759,454 | 679,629 | 710,447 | 921,344 | 714,627 | 953,513 | 726,494 | 848,601 | 789,496 | 724,326 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 51,706 | 310 | 12,237 | 20,783 | 7,003 | 5,414 | 3,157 | 4,255 | 6,241 | 6,295 | 3,875 | 7,861 | 6,025 | 1,140 |
Group/Directors Accounts | 784,208 | 1,687,245 | 2,613,721 | 1,634,313 | 12,545 | 82,640 | 128,099 | 78,390 | 20,650 | 257,645 | 140,624 | 346,953 | 320,405 | 297,213 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 719,340 | 434,838 | 1,084,560 | 610,270 | 237,485 | 239,123 | 203,523 | 203,580 | 122,433 | 162,370 | 99,092 | 65,670 | 78,408 | 80,826 |
total current liabilities | 1,555,254 | 2,122,393 | 3,710,518 | 2,265,366 | 257,033 | 327,176 | 334,779 | 286,225 | 149,324 | 426,310 | 243,591 | 420,484 | 404,838 | 379,179 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 500,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 248 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 500,000 | 0 | 0 | 0 | 0 | 248 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 1,555,254 | 2,122,393 | 3,710,518 | 2,765,366 | 257,033 | 327,176 | 334,779 | 286,225 | 149,572 | 426,310 | 243,591 | 420,484 | 404,838 | 379,179 |
net assets | 1,394,380 | 1,109,188 | 881,560 | 755,469 | 502,421 | 352,453 | 375,668 | 635,119 | 565,055 | 527,203 | 482,903 | 428,117 | 384,658 | 345,147 |
total shareholders funds | 1,394,380 | 1,109,188 | 881,560 | 755,469 | 502,421 | 352,453 | 375,668 | 635,119 | 565,055 | 527,203 | 482,903 | 428,117 | 384,658 | 345,147 |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | 364,673 | 330,307 | 356,678 | 190,289 | 174,077 | 82,630 | 87,189 | 51,043 | 57,566 | 63,636 | 59,663 | 63,770 | 102,077 | |
Depreciation | 266 | 0 | 0 | 0 | 0 | 0 | 0 | 1,190 | 2,979 | 2,952 | 2,214 | 0 | 0 | 0 |
Amortisation | 360,000 | 360,000 | 360,000 | 210,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | -138,780 | -170,636 | -65,588 | -41,416 | -37,478 | -29,002 | -23,151 | -17,326 | -19,470 | -15,617 | -10,588 | -21,440 | -28,131 | |
Stock | -114,845 | 261,782 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 134,944 | -1,564,553 | 1,532,280 | 950,809 | 238,037 | 5,827 | 67,217 | 107,005 | -291,853 | -9,868 | -156,183 | 38,868 | 182,420 | 528,402 |
Creditors | 51,396 | -11,927 | -8,546 | 13,780 | 1,589 | 2,257 | -1,098 | -1,986 | -54 | 2,420 | -3,986 | 1,836 | 4,885 | 1,140 |
Accruals and Deferred Income | 284,502 | -649,722 | 474,290 | 372,785 | -1,638 | 35,600 | -57 | 81,147 | -39,937 | 63,278 | 33,422 | -12,738 | -2,418 | 80,826 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -248 | 248 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | 1,227,015 | -546,865 | -63,154 | -89,213 | 168,629 | -14,744 | 37,136 | 288,806 | 116,614 | 235,852 | -695 | -137,623 | -372,490 | |
Investing Activities | ||||||||||||||
capital expenditure | 0 | -479 | 0 | -8,856 | 0 | 0 | 3,357 | |||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | 0 | -479 | 0 | -8,856 | 0 | 0 | 3,357 | |||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -903,037 | -926,476 | 979,408 | 1,621,768 | -70,095 | -45,459 | 49,709 | 57,740 | -236,995 | 117,021 | -206,329 | 26,548 | 23,192 | 297,213 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | -500,000 | 500,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | 1,735 | -33,580 | -38,042 | 1,095 | 0 | -37,089 | -6,026 | 0 | 5,687 | 6,767 | -5,616 | -2,819 | 73 | |
cash flow from financing | -924,741 | 445,828 | 2,083,726 | -69,000 | -45,459 | 12,620 | 51,714 | -236,996 | 122,708 | -199,562 | 20,932 | 20,373 | 568,414 | |
cash and cash equivalents | ||||||||||||||
cash | 56,850 | 102,274 | 98,963 | 220,572 | -158,213 | -36,644 | -278,114 | 100,902 | 55,467 | 239,839 | 27,434 | 20,237 | -117,250 | 195,924 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 56,850 | 102,274 | 98,963 | 220,572 | -158,213 | -36,644 | -278,114 | 100,902 | 55,467 | 239,839 | 27,434 | 20,237 | -117,250 | 195,924 |
vitrolife limited Credit Report and Business Information
Vitrolife Limited Competitor Analysis
Perform a competitor analysis for vitrolife limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
vitrolife limited Ownership
VITROLIFE LIMITED group structure
Vitrolife Limited has no subsidiary companies.
Ultimate parent company
VITROLIFE AB
#0036161
1 parent
VITROLIFE LIMITED
04628698
vitrolife limited directors
Vitrolife Limited currently has 2 directors. The longest serving directors include Mr Bo Risberg (Jan 2022) and Mr Tony Tolf (Jan 2022).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Bo Risberg | Sweden | 55 years | Jan 2022 | - | Director |
Mr Tony Tolf | Sweden | 54 years | Jan 2022 | - | Director |
P&L
December 2022turnover
7.4m
-9%
operating profit
334.6k
0%
gross margin
55.6%
+96.55%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
1.4m
+0.26%
total assets
2.9m
-0.09%
cash
528.2k
+0.12%
net assets
Total assets minus all liabilities
vitrolife limited company details
company number
04628698
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
January 2003
age
21
accounts
Small Company
ultimate parent company
previous names
ivf limited (November 2009)
incorporated
UK
address
1 chapel street, warwick, CV34 4HL
last accounts submitted
December 2022
vitrolife limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to vitrolife limited.
vitrolife limited Companies House Filings - See Documents
date | description | view/download |
---|